Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.21.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock [Member]
Class A Units [Member]
Class B Units [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2019 $ 2,000 $ 68,028,000 $ (56,585,000) $ 11,445,000
Balance, shares at Dec. 31, 2019 4,396 24,496,197      
Sale of common stock from private placement $ 1,000 3,429,000 3,430,000
Sale of common stock from private placement, shares 3,392,833      
Fair value of warrants issued to Series A Preferred stockholders (3,951,000) (3,951,000)
Conversion of Series A Preferred to common stock
Conversion of Series A Preferred to common stock, shares (1,150) 741,933      
Fair value of common shares issued for services 321,000 321,000
Fair value of common shares issued for services, shares 320,601      
Fair value of vested restricted stock awards 241,000 241,000
Fair value of vested restricted stock awards, shares 11,025      
Fair value of vested stock options and warrants 381,000 381,000
Net loss (1,946,000) (1,946,000)
Balance at Mar. 31, 2020 $ 3,000 68,449,000 (58,531,000) 9,921,000
Balance, shares at Mar. 31, 2020 3,246 28,962,589      
Balance at Dec. 31, 2020 $ 3,065,000 $ 5,000 89,216,000 (81,541,000) 10,745,000
Balance, shares at Dec. 31, 2020 2,006 2,642,159 47,795,009      
Conversion of Series A Preferred to common stock
Conversion of Series A Preferred to common stock, shares (300) 272,728      
Fair value of common shares issued for services 1,414,000 1,414,000
Fair value of common shares issued for services, shares 809,511      
Fair value of vested restricted stock awards 447,000 447,000
Fair value of vested restricted stock awards, shares 247,703      
Fair value of vested stock options and warrants 448,000 448,000
Sale of common stock from public offering $ 1,000 14,128,000 14,129,000
Sale of common stock from public offering, shares 9,375,000      
Issuance of common stock from warrant exercise 1,103,000 1,103,000
Issuance of common stock from warrant exercise, shares 1,036,600      
Issuance of common stock from option exercise 377,000 $ 377,000
Issuance of common stock from option exercise, shares 332,730     332,730
Extinguishment of derivative liability upon exercise of warrants 2,286,000 $ 2,286,000
Fair value of common shares issued to settle accrued expenses 207,000 207,000
Fair value of common shares issued to settle accrued expenses, shares 121,842      
Fair value of warrants issued to officer to modify note payable 287,000 287,000
Conversion of Class B Units to common shares $ (3,065,000) 3,065,000
Conversion of Class B Units to common shares, shares (2,642,159) 2,642,159      
Net loss (8,345,000) (8,345,000)
Balance at Mar. 31, 2021 $ 6,000 $ 112,978,000 $ (89,886,000) $ 23,098,000
Balance, shares at Mar. 31, 2021 1,706 62,633,282